Piotr Sikorski

Piotr Sikorski

Auto-generated profile, based on publicly available information

Piotr Sikorski

Student Research Club Department of Ophthalmology Infant Jesus Teaching Hospital Medical University of Warsaw Warsaw Poland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2024 in European Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
MDMartyna Dyrek
Martyna Dyrek
ESEwa Sikorska
Ewa Sikorska
APAleksandra Partyka
Aleksandra Partyka
PSPiotr Sikorski
Piotr Sikorski
EDEdyta Dusza
Edyta Dusza
DKDorota Kopacz
Dorota Kopacz
Introduction and aim. Recently, an increased use of video display terminals has been observed in workplace environments, as a result of the evolution of communication technologies and new information-sharing strategies. It has led to an increased prevalence of computer-related ocular disorders, such as computer vision syndrome, dry eye disease, refractive errors and con vergence insufficiency. In this review we describe problems associated with these disorders and propose preventive methods. Material and methods. With the use of specific keywords, the databases of the PubMed, Science Direct, and Google Scholar were searched for relevant original papers. Analysis of the literature. The listed disorders might have similar symptoms, such as eye burning, itching, blurred vision, and tearing, and their severity correlates with the time of exposure to video display units. However, there are preventive measures, which can help in decreasing the negative effects of computers on our vision, such as adequate viewing distance, proper work space lighting, eyeglasses with anti-glare coating, taking 5-minutes breaks after every 30 minutes, or following the 20-20-20 rule. Conclusion. Prolonged usage of the video display terminals is connected to many ocular disorders, and in today’s world, it is very important to remember actions that can be undertaken to minimize the risk.

17 May 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
PSPiotr Sikorski
Piotr Sikorski
PMPiotr Malinowski
Piotr Malinowski
UKUrszula Kopczyńska
Urszula Kopczyńska
CKCezary Kopczyński
Cezary Kopczyński
KGKinga Gurdak
Kinga Gurdak
APAleksandra Partyka
Aleksandra Partyka
Withania somnifera, commonly known as ashwagandha, has gained popularity in recent years among individuals interested in healthy lifestyles, natural medicine, and sports. This review aims to summarize the current knowledge regarding the effects of ashwagandha supplementation on various aspects of physical performance, particularly in the context of resistance training. Studies have shown that ashwagandha can positively impact muscle strength, with significant increase of muscle force and power output. Additionally, it has demonstrated potential in modulating body composition, with reduction of body fat percentage noted in certain populations. However, results of studies on ashwagandha’s effect on muscle size remain inconclusive and may depend on various factors such as training status and individual responses. In terms of endurance, ashwagandha supplementation has been associated with improvement in maximal oxygen uptake, indicating enhanced aerobic capacity and delayed exhaustion during endurance activities. Furthermore, ashwagandha was shown to aid muscle recovery by reducing exercise-induced muscle damage and inflammatory response, potentially accelerating the muscle regeneration process. Ashwagandha may also influence hormone levels, such as testosterone and cortisol, with potential implications for muscle growth and recovery. However, further research is needed to fully understand the mechanisms underlying these effects. Overall, ashwagandha supplementation appears to hold promise for enhancing physical performance and overall well-being. Further research is needed to elucidate optimal dosages, long-term safety, and potential interactions with other supplements or medications.

23 May 2023 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
MMMilena Nikola Michalska
Milena Nikola Michalska
ASAlbert Stec
Albert Stec
ZLZuzanna Lubaszka
Zuzanna Lubaszka
UŻUrszula Żurek
Urszula Żurek
JFJakub Fiega
Jakub Fiega
ESEwa Sikorska
Ewa Sikorska
Insulin resistance is a growing concern worldwide, affecting millions of people and increasing the risk of various metabolic disorders, including type 2 diabetes, cardiovascular diseases, and fatty liver disease. This paper aims to display the symptoms of insulin resistance and the importance of early detection through various diagnostic tests such as fasting insulin levels, oral glucose tolerance tests, and HOMA-IR scores. Despite the high prevalence of insulin resistance, there is currently no known cure for this condition as it is not a disease in itself. However, lifestyle modifications, including exercise and dietary changes, can effectively manage and prevent the progression of insulin resistance and its associated complications. This study emphasizes the importance of raising awareness about insulin resistance and its adverse effects on individuals' health and the healthcare system's burden. Early detection and management of insulin resistance can significantly reduce the risk of developing metabolic disorders and prevent serious health complications.

30 March 2024 in European Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
APAleksandra Partyka
Aleksandra Partyka
MDMartyna Dyrek
Martyna Dyrek
PSPiotr Sikorski
Piotr Sikorski
ESEwa Sikorska
Ewa Sikorska
Introduction and aim. Blue light is part of the natural light spectrum and plays a role in regulating the circadian rhythm. However, with the increasing use of electronic devices and energy-efficient lighting emitting high levels of artificial blue light, concerns are raised regarding its potential effect on human health. Blue-blocking filters have been developed and are adver tised as a solution to be used in spectacles or intraocular lenses. This review aims to provide an in-depth analysis of the use of blue-blocking filters based on the results of clinical trials. Material and methods. This review included relevant original papers reporting on clinical trial results from PubMed, Science Direct, and Google Scholar databases using specified keywords. Analysis of the literature. Trials conducted with patients reveal mixed results, with some showing no significant changes in vision and reading abilities, while others indicating potential limitations such as reduced contrast vision. However, blue-blocking filters have demonstrated potential benefits in improving sleep quality and mood, particularly in patients with sleep disturbances or psychiatric disorders. The efficacy of blue-blocking filters in mitigating symptoms of digital eye strain remains inconclusive. Conclusion. Overall, this paper provides a comprehensive assessment of the benefits and limitations associated with the use of blue-blocking filters, highlighting the need for further investigation in certain areas.

17 May 2023 in Current Problems of Psychiatry
Verified
Journal Article
Open access
PSPiotr Sikorski
Piotr Sikorski
ESEwa Sikorska
Ewa Sikorska
MMMilena Nikola Michalska
Milena Nikola Michalska
ASAlbert Stec
Albert Stec
KKKaja Kasarełło
Kaja Kasarełło
SFSylwia Fudalej
Sylwia Fudalej
Introduction: There are several hypotheses of schizophrenia pathogenesis, including the neurodegenerative theory, which is supported by evidence for the decrease of neuroprotective factors’ serum levels. The proteins, that exert a protective effect on neurons and are researched concerning schizophrenia pathogenesis, include the brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), neurotrophin 3 (NT3), and glial cell line-derived neurotrophic factor (GDNF). This review aims to discuss the role of neuroprotective factors in the development of schizophrenia and their relevance in clinical trials. Material and methods: This review was performed by search of the PubMed, Google Scholar, and Science Direct databases from December 25th, 2022, through January 31st, 2023, using keywords: ‘schizophrenia’, ‘schizophrenia pathogenesis’, ‘neuroprotection’, ‘neurodegeneration’, ‘BDNF’, ‘NGF’, ‘NT3’, and ‘GDNF’. We considered original research papers and systematic reviews published in English or Polish. Additionally, clinical trials, which included the assessment of neuroprotective factors’ levels in schizophrenia as outcome measures, were searched for on clinicaltrials.gov. Results: Lower levels of serum BDNF have been linked to cognitive impairment in schizophrenia. In clinical trials, the assessment of serum BDNF is used as a clinical outcome measure for novel schizophrenia therapies. Schizophrenia has also been associated with reduced peripheral NGF levels. During remission, lower NGF levels correlate with higher severity of negative symptoms. Decreased NT3 and GDNF levels can also be seen, but literature reports are inconsistent. Conclusions: Neuroprotective factors are most likely related to the pathogenesis of schizophrenia. Assessing the serum level of these proteins may prove to be an invaluable element of schizophrenia management. Keywords: schizophrenia, brain-derived neurotrophic factor, nerve growth factor,neurotrophin 3, glial cell line-derived neurotrophic factor

23 October 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
CKCezary Kopczyński
Cezary Kopczyński
UKUrszula Kopczyńska
Urszula Kopczyńska
PMPiotr Malinowski
Piotr Malinowski
PSPiotr Sikorski
Piotr Sikorski
KGKinga Gurdak
Kinga Gurdak
APAleksandra Partyka
Aleksandra Partyka
Post-dural puncture headache (PDPH) is a common complication following spinal procedures, particularly lumbar punctures and epidural anesthesia. This systematic review aims to evaluate and compare the effectiveness of various management strategies for PDPH. A comprehensive search was conducted across major databases for relevant articles published up to January 2024. The inclusion criteria comprised studies assessing interventions for post-dural puncture headache (PDPH) management in adult populations. Data extraction and quality evaluation were conducted independently by two reviewers. Analysis involved 34 studies meeting the inclusion criteria. The results indicate that conservative approaches, including bed rest, hydration, caffeine, and analgesics, continue to serve as the fundamental components of PDPH management. Additionally, epidural blood patch (EBP) emerged as the most effective intervention for refractory cases. However, further research is needed to optimize treatment protocols and explore emerging therapies.